Demonstration of antibodies against SARS-CoV-2, neutralizing or binding, in seroconversion panels after mRNA-1273, BNT-162b2 and Ad26.COV2.S vaccine administration.
暂无分享,去创建一个
S. Marfil | M. Massanella | J. Blanco | A. Vivanco | Edwards Pradenas | O. Mora | N. Torres | F. Belda | R. Christie | M. Crowley | M. López-Martínez